Delivery Order SPE2DR25D3012-SPE2DR26F4E1B
Award Date 12/29/25
Potential Completion Date 12/30/25
Potential Value $5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $14.7K delivery order to AmerisourceBergen Drug Corp for 50 mg vials of AmBisome, an antifungal medication used for serious systemic fungal infections. The contract, awarded on July 24, 2025, with completion targeted for July 25, 2025, utilizes firm fixed pricing with no set-aside designation. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order valued at $7,788.50 to AmerisourceBergen Drug Corp for 50 mg vials of AmBisome, an antifungal medication used to treat serious fungal infections in military and federal healthcare settings. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by December 9, 2025. The award was issued on December 8, 2025, with performance taking place at the contractor's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,720.51 to AmerisourceBergen Drug Corp for the supply of AmBisome 50 mg vials. This firm fixed price, competitively awarded delivery order is scheduled for completion by December 5, 2025, with performance at the company's corporate headquarters in Conshohocken, Pennsylvania. AmBisome is a liposomal amphotericin B formulation used for treating serious fungal infections, representing a critical pharmaceutical commodity for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of AmBisome 50 mg vials, a critical antifungal medication used in military and federal healthcare systems. This competitively awarded, non-set-aside contract is valued at $16,184.74 with a firm fixed price structure and an ultimate completion date of August 5, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 1, 2025, for the supply of AmBisome 50 mg vials, a specialized antifungal pharmaceutical product. This competitively awarded, non-set-aside contract carries a ceiling value of $7,741.00 with firm fixed pricing and an ultimate completion date of September 2, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of AmBisome 50 mg vials, a specialized pharmaceutical product used in military and federal healthcare systems. This firm fixed-price delivery order, valued at $11,016.77, was competitively awarded without set-aside designation and is scheduled for completion by August 8, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,098.20 order is for the supply of the antifungal medication AMBISOME 50 MG VIALS. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA Troop Support Medical and Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,846.96 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,153,581 units of AMBISOME 50 MG VIALS by December 21, 2023. As a prime contractor, Amerisourcebergen Drug Corp has a long history of supplying pharmaceuticals, medical supplies, and distribution services to DLA Troop Support Medical facilities. This delivery order was not set aside and is part of...
- This federal contract award is for the delivery of AmBisome 50 mg vials, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,923.48 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., holds with the DLA Troop...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distributor, to provide AMBISOME 50 MG VIALS. The order has a potential value of $6,210.92 and a completion date of February 22, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, serves as the prime contractor. This award is part of a larger indefinite delivery contract (IDC) valued at up to...